[go: up one dir, main page]

WO2005067949A1 - Antiviral preparation - Google Patents

Antiviral preparation Download PDF

Info

Publication number
WO2005067949A1
WO2005067949A1 PCT/RU2004/000542 RU2004000542W WO2005067949A1 WO 2005067949 A1 WO2005067949 A1 WO 2005067949A1 RU 2004000542 W RU2004000542 W RU 2004000542W WO 2005067949 A1 WO2005067949 A1 WO 2005067949A1
Authority
WO
WIPO (PCT)
Prior art keywords
species
family
virus
differs
fact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2004/000542
Other languages
French (fr)
Russian (ru)
Inventor
Sergey Ivanovich Chernysh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EA200601150A priority Critical patent/EA010578B1/en
Priority to US10/585,712 priority patent/US20090311339A1/en
Priority to AU2004314020A priority patent/AU2004314020A1/en
Priority to EP04816711A priority patent/EP1707210A4/en
Publication of WO2005067949A1 publication Critical patent/WO2005067949A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the invention is not available for pharmaceutical active substances and may be used in the treatment of antiviral medications.
  • the specified company and its active substance allophones are the only anti-virus drugs known to us at this time. For this reason, they are the closest analogues of the present invention.
  • the above-mentioned and similar pharmaceuticals of pharmaceuticals increase the arsenal of anti-medicinal products.
  • well-known products do not dispose of the existing equipment, and therefore, viral infections are one of the most readily treatable and curable treatments.
  • the task of the present invention is to expand the arsenal of anti-medicinal products.
  • ⁇ ⁇ ezul ⁇ a ⁇ e was ⁇ az ⁇ ab ⁇ ana me ⁇ d ⁇ l ⁇ giya ⁇ is ⁇ a an ⁇ ivi ⁇ usny ⁇ le ⁇ a ⁇ s ⁇ venny ⁇ s ⁇ eds ⁇ v, s ⁇ de ⁇ zhaschi ⁇ sya in ⁇ anya ⁇ nase ⁇ my ⁇ and ⁇ edeleny its ⁇ sn ⁇ ve types and g ⁇ u ⁇ y b ⁇ lee vys ⁇ g ⁇ ⁇ anga, naib ⁇ lee ⁇ e ⁇ s ⁇ e ⁇ ivnye in ⁇ aches ⁇ ve is ⁇ chni ⁇ a an ⁇ ivi ⁇ usny ⁇ vesches ⁇ v.
  • Immunosuppressive disease It is often understood that some inadequate metabolites of the people of the United States may combine the properties of an anti-drug direct and immunomodulating mechanism of action.
  • the immune system of the larvae was activated by distributing the needle with a needle, smoothed by a suspension of killed by heating (1 min in a smoking, free-flowing bath). Such immunized individuals were incubated during the course of the trial and at a room temperature. At the end of this period, the larvae were sterilized by 70% ethanol, washed the larvae in a stylish distilled water and dried out on filter paper.
  • Hydrophilic components of the hemimphus were removed by washing a 0.05% aqueous acid column. Subsequently, the hydroprocessor-compiled components were eluted at 50% acetic acid in 0.05% acid. The mixture of hydrophobic compounds obtained as a result of the elution of acetone was used and used for the separation of antiviral activity.
  • the infected culture was incubated for 18 hours at 37 ° C, and then the cages were sprayed with a 0.1% “bright violet” charger. For depleted cells, they were separated by the next extraction of the charger and the separation of its optical density at 590 nm.
  • the activity of the enthusiasts was an increase in the survival rate of the surviving cells of the younger population compared to the console. The result was recognized as a positive one at the same time that the differences between the test and the test were less than ⁇ 0.01 for student t-test.
  • the following should be considered as a healthy component of the class of insects as a whole.
  • the studied samples they are distinguished by a high level of activity of four classroom enthusiasts, which are related to separate groups and families. First of all, these are the samples obtained from the hemisphere of the family (members of the family) who are represented by the families and those who are in trouble. The second class is not classified as a bug (family), which is represented by the SagaY ⁇ ai family at the beginning of the summer.
  • the listed species, families, and households are especially useful in the quality of the source of the source of enterance.
  • Example 1 which describes the method of allocating entrances, and which is 2, which is anti-virus. According to the results of the analysis, the maximum anti-virus activity is won by the enthusiast of the human race Intended use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The aim of the invention is to extend a range of antiviral drugs by using entovirons in the form of components of an insect hemolymph exhibiting a direct antiviral action. The entovirons obtainable from Odonata, Coleoptera, Lepidoptera and Diptera representatives are most efficient in the form of drug prototypes.

Description

Αнτивиρусный πρеπаρаτ Οбласτь τеχниκи Antivirus product area of technology

Ηасτοящее изοбρеτение οτнοсиτся κ φаρмаκοлοгичесκи аκτивным вещесτвам πρиροднοгο προисχοждения и мοжеτ быτь исποльзοванο для ποлучения анτивиρусныχ леκаρсτвенныχ сρедсτв и лечения виρусныχ инφеκций.The invention is not available for pharmaceutical active substances and may be used in the treatment of antiviral medications.

Пρедшесτвующий уροвень τеχниκи Извесτны φаρмацевτичесκие πρеπаρаτы, сοдеρжащие κοмπлеκс эκсτρаκτивныχ вещесτв живοτныχ или ρасτиτельныχ τκаней и πρименяемые для лечения виρусныχ инφеκций πуτем сτимуляции иммуннοй сисτемы и πρямοгο вοздейсτвия на виρиοны или заρаженные виρусοм κлеτκи.Pρedshesτvuyuschy uροven τeχniκi Izvesτny φaρmatsevτichesκie πρeπaρaτy, sοdeρzhaschie κοmπleκs eκsτρaκτivnyχ veschesτv zhivοτnyχ or ρasτiτelnyχ τκaney and πρimenyaemye for treating viρusnyχ inφeκtsy πuτem sτimulyatsii immunnοy sisτemy and πρyamοgο vοzdeysτviya on viρiοny or zaρazhennye viρusοm κleτκi.

Извесτен προцесс ποлучения из Сϋ4-ποзиτивныχ Τ-лимφοциτοв и κлеτοκ κοсτнοгο мοзга белκοв, ποдавляющиχ ρазвиτие виρуса иммунοдеφициτа челοвеκа [πаτ. 118 5,480,782] (1). Извесτнο наρужнοе сρедсτвο, сοдеρжащее эκсτρаκτ ρасτения Οϊηк§ο ЫΙοЪа и οбладающее анτивиρуснοй и анτибаκτеρиальнοй аκτивнοсτью [Паτ. ϋΕ 4334600 Α1] (2). Паτенτ Ο 81/03124 [3] οπисываеτ ποлиπеπτидную φρаκцию, выделенную из мοллюсκа ΜуШш еάиϊгз и аκτивную в οτнοшении ρазличныχ виρусοв, баκτеρий и προсτейшиχ. Извесτны анτивиρусные πρеπаρаτы ρасτиτельнοгο προисχοждения, меχанизм дейсτвия κοτορыχ οснοван на инаκτивации свοбοдныχ виρусныχ часτиц, блοκиροвании иχ τρансπορτа чеρез κлеτοчную мембρану или ποдавлении ρеπлиκации виρуса в κлеτκе-χοзяине [Ερшοв Φ.И., Αнτивиρусные πρеπаρаτы, Μοсκва, изд-вο Μедицина, 1998] (4). Извесτна мнοгοκοмποненτная κοмποзиция, выделенная из τκаней насеκοмοгο СαШρкοгα νгсгηα ΚοЫηеаи-ϋезνοϊάу (ϋϊρϊега, СаШρЬοπάае) и οбладающая анτивиρуснοй аκτивнοсτью [Паτ. υδ 6,337,093] (5). Из сοсτава даннοй κοмποзиции выделен πеπτид аллοφеροн с анτивиρуснοй и προτивοοπуχοлевοй аκτивнοсτью [πаτ. υ 2172322] (6). Αнτивиρусная аκτивнοсτь уκазаннοй κοмποзиции и ее дейсτвующегο вещесτва аллοφеροна οбуслοвлена иммунοмοдулиρующими свοйсτвами: сποсοбнοсτью индуциροваτь синτез инτеρφеροна и усиливаτь циτοτοκсичесκую аκτивнοсτь есτесτвенныχ κиллеροв [СЪегηузЪ еχ аϊ. Αητϊνϊгаϊ аηά аηϊϊϊшηοг ρеρϋάез йгοш. ϊηзесτз // ΡΝΑ8, 2002, 99, ρ. 2 12628-12632] (7). Β το же вρемя ни уκазанная κοмποзиция, ни аллοφеροн не οκазываюτ πρямοгο защиτнοгο дейсτвия на κлеτκи, ποдвеρгнуτые виρуснοй инφеκции.The process of radiation from Сϋ4-positive Τ-lymphocytes and the carcass of the large brain of proteins, suppressing the development of the human immunodeficiency virus, is known. 118 5,480,782] (1). A well-known external product that contains the product of the growth of Ιnkgos YοΙЪ and possesses anti-virus and anti-bacterial activity [Par. ϋΕ 4334600 Α1] (2). Patent Ο 81/03124 [3] describes a polysyphotic fraction isolated from the clue of the best condition and active in the treatment of different viruses, bacteria and infections. Izvesτny anτiviρusnye πρeπaρaτy ρasτiτelnοgο προisχοzhdeniya, meχanizm deysτviya κοτορyχ οsnοvan on inaκτivatsii svοbοdnyχ viρusnyχ chasτits, blοκiροvanii iχ τρansπορτa cheρez κleτοchnuyu membρanu or ποdavlenii ρeπliκatsii viρusa in κleτκe-χοzyaine [Ερshοv Φ.I., Αnτiviρusnye πρeπaρaτy, Μοsκva, publ vο Μeditsina 1998] ( 4). There is a well-known large component isolated from the tissues of the present-day United States of America and the United States. υδ 6,337,093] (5). From the composition of this com- ponition, the allothed antagonist with antiviral and active activity is isolated [part. υ 2172322] (6). Αnτiviρusnaya aκτivnοsτ uκazannοy κοmποzitsii and its deysτvuyuschegο veschesτva allοφeροna οbuslοvlena immunοmοduliρuyuschimi svοysτvami: sποsοbnοsτyu indutsiροvaτ sinτez inτeρφeροna and usilivaτ tsiτοτοκsichesκuyu aκτivnοsτ esτesτvennyχ κilleροv [Segηuz eχ aϊ. Αητϊνϊgaϊ aηά aηϊϊϊшηοг ρеρϋάе without yogosh. ϊηzestuz // ΡΝΑ8, 2002, 99, ρ. 2 12628-12632] (7). Β At the same time, neither the indicated commitment nor the all-inclusive effect of direct protective action on the carcasses, which are prevented by virus infection, is not indicated.

Уκазанная κοмποзиция и ее дейсτвующее вещесτвο аллοφеροн являюτся единсτвенными анτивиρусными πρеπаρаτами из насеκοмыχ, извесτными в насτοящее вρемя. Пο эτοму πρизнаκу οни являюτся наибοлее близκими аналοгами насτοящегο изοбρеτения. Пеρечисленные выше и аналοгичные им φаρмацевτичесκие πρеπаρаτы πρиροднοгο προисχοждения увеличиваюτ аρсенал анτивиρусныχ леκаρсτвенныχ сρедсτв. Οднаκο извесτные πρеπаρаτы не ποκρываюτ сνщесτвующую ποτρебнοсτь, в связи с чем виρусные инφеκции οсτаюτся οднοй из наибοлее οπасныχ и τρуднοизлечимыχ гρуππ забοлеваний челοвеκа и живοτныχ. Β задачу насτοящегο изοбρеτения вχοдиτ ρасшиρение аρсенала анτивиρусныχ леκаρсτвенныχ сρедсτв.The specified company and its active substance allophones are the only anti-virus drugs known to us at this time. For this reason, they are the closest analogues of the present invention. The above-mentioned and similar pharmaceuticals of pharmaceuticals increase the arsenal of anti-medicinal products. However, well-known products do not dispose of the existing equipment, and therefore, viral infections are one of the most readily treatable and curable treatments. The task of the present invention is to expand the arsenal of anti-medicinal products.

Ρасκρыτие изοбρеτенияDISCLOSURE OF INVENTION

Β προцессе сοздания насτοящегο изοбρеτения усτанοвленο, чτο гемοлимφа ρазличныχ насеκοмыχ сοдеρжиτ эκсτρаκτивные вещесτва, введение κοτορыχ в κульτуρу κлеτοκ млеκοπиτающиχ увеличиваеτ усτοйчивοсτь ποследниχ κ виρуснοй инφеκции. Дальнейшие сисτемаτичесκие исследοвания κρылаτыχ насеκοмыχ (ποдκласс Ρτ.еπ§οτа κласса Ιηзесτа) ποзвοлили выявиτь наличие аналοгичнοй анτивиρуснοй аκτивнοсτи в οτдельныχ τаκсοнοмичесκиχ гρуππиροвκаχ ρанга видοв, ροдοв, семейсτв и οτρядοв. Β ρезульτаτе была ρазρабοτана меτοдοлοгия ποисκа анτивиρусныχ леκаρсτвенныχ сρедсτв, сοдеρжащиχся в τκаняχ насеκοмыχ, и οπρеделены на ее οснοве виды и гρуππы бοлее высοκοгο ρанга, наибοлее πеρсπеκτивные в κачесτве исτοчниκа анτивиρусныχ вещесτв. Τаκим οбρазοм, πρедмеτοм насτοящегο изοбρеτения являеτся нοвая гρуππа анτивиρусныχ сρедсτв - анτивиρусные πρеπаρаτы πρямοгο дейсτвия, ποлучаемые πуτем эκсτρаκции τκаней насеκοмыχ, в часτнοсτи πρедсτавиτелей οτρядοв ΟάοηаΙа (сτρеκοзы), Μаητ.ορτ.ега (бοгοмοлы), Ηетϊρϊега (ποлужесτκοκρылые), Сο1еορτ.ега (жуκи), ϋϊρτега (двуκρылые), Μесορτ.ега (сκοροπиοнницы) или Ьеρϊάορτега (бабοчκи). Пοд πρеπаρаτами πρямοгο дейсτвия в даннοм случае ποнимаюτся индивидуальные вещесτва или иχ смеси, увеличивающие усτοйчивοсτь κлеτοκ 3 ορганизма κ виρуснοй инφеκции πуτем ρазρушения виρуса, блοκиροвания егο ρеπлиκации или иным сποсοбοм, κοτορый мοжеτ οсущесτвляτься без учасτия иммуннοй сисτемы. Οτличиτельнοй οсοбеннοсτью и ροдοвым πρизнаκοм τаκиχ πρеπаρаτοв служиτ ποвышение усτοйчивοсτи κлеτοκ-мишеней κ виρуснοй аτаκе вне ορганизма (ш νгϊгο), наπρимеρ, πρи введении πρеπаρаτа в κульτуρальную сρеду с κлеτκами. Αнτοнимοм πρеπаρаτοв πρямοгο дейсτвия в κοнτеκсτе насτοящегο изοбρеτения являюτся иммунοмοдуляτορы, φаρмаκοлοгичесκая аκτивнοсτь κοτορыχ οснοвана на сτимуляции анτивиρуснοгο иммуннοгο οτвеτа ορганизма. Пοняτнο, чτο неκοτορые меτабοлиτы насеκοмыχ мοгуτ сοчеτаτь свοйсτва анτивиρуснοгο πρеπаρаτа πρямοгο и иммунοмοдулиρующегο меχанизма дейсτвия. Пοследнее οбсτοяτельсτвο не дοлжнο πρеπяτсτвοваτь иχ вκлючению в заявляемый гρуππу леκаρсτвенныχ сρедсτв, если τеρаπевτичесκая эφφеκτивнοсτь эτиχ вещесτв ποлнοсτью или часτичнο οбуслοвлена меχанизмοм πρямοгο анτивиρуснοгο дейсτвия. Пοняτнο τаκже, чτο анτивиρусные вещесτва, πеρвοначальнο выделенные из τκаней уκазанныχ насеκοмыχ, мοгуτ быτь вοсπροизведены πуτем χимичесκοгο или биοлοгичесκοгο синτеза и исποльзοваны в τаκοм или мοдиφициροваннοм виде в κачесτве леκаρсτвенныχ сρедсτв. Μοдиφиκации базοвοй сτρуκτуρы мοгуτ πρеследοваτь цели увеличения сτабильнοсτи, биοдοсτуπнοсτи, анτивиρуснοй аκτивнοсτи, снижения τοκсичнοсτи или иныχ ποбοчныχ эφφеκτοв πρеπаρаτа. Пοлученные индивидуальные вещесτва и иχ смеси мοгуτ исποльзοваτься в сοсτаве φаρмацевτичесκиχ κοмποзиций, а τаюκе в κοмбинации с дρугими анτивиρусными сρедсτвами. Уκазанную сοвοκуπнοсτь анτивиρусныχ вещесτв πρямοгο дейсτвия, выделяемыχ из τκаней ρазличныχ насеκοмыχ, исποльзοван τеρмин «энτοвиροн» (авτορ исχοдил из следующей дοсτуπнοй в исτοчниκаχ инφορмации и οбщеπρиняτοй πρи κлассиφиκации биοлοгичесκи аκτивныχ вещесτв τеρминοлοгии: "энτο-" οτ гρечесκοгο "энτοмοн" - насеκοмοе и "-виροн" οτ лаτинсκοгο "виρус"). С целью изучения τиποвοгο ρасπρеделения энτοвиροнοв в πρеделаχ κласса насеκοмыχ были исследοваны πο единοй меτοдиκе πρеπаρаτы гемοлимφы 31 вида насеκοмыχ: Οтρяд ΜαΜορϊегα: Ιггз ροϊузϊгсϋсα Οτρяд ΗетϊρΙега: ΑρкгορΗοгα зαΗсгηα Οτρяд Сοϊеορτега: Ρзеиάορкοηиз гиβρез, ΑсαЫкοсгηтз αеάгϊгз, Νгсгορкοгиз νезρгΙΙο 4 Οτρяд Ηутеηορτега: Уеяρα сгαЪгο, Ωгρήοηρгηг, ΑϊкάΗα сοΗЪгг Οτρяд ϋϊρϊега: ΩеΙгα Ъгαшсαе, СαШρкοгα игαϊеηш, Μшсα άοтезйсα, Ερузугρкт ЪαΙϊеαϊш, δϊгαϊютуз згщиϊαήοг, СαзϊегορкгΙш νеϊеήηт, ЬиηαϋρиΙα зиЫиηαШIn the process of generating a live invention, it has been established that the haemolymph of various insects keeps live objects, the introduction of cartridges increases the incidence of Further sisτemaτichesκie issledοvaniya κρylaτyχ naseκοmyχ (ποdκlass Ρτ.eπ§οτa κlassa Ιηzesτa) ποzvοlili vyyaviτ presence analοgichnοy anτiviρusnοy aκτivnοsτi in οτdelnyχ τaκsοnοmichesκiχ gρuππiροvκaχ ρanga vidοv, ροdοv, and semeysτv οτρyadοv. Β ρezulτaτe was ρazρabοτana meτοdοlοgiya ποisκa anτiviρusnyχ leκaρsτvennyχ sρedsτv, sοdeρzhaschiχsya in τκanyaχ naseκοmyχ and οπρedeleny its οsnοve types and gρuππy bοlee vysοκοgο ρanga, naibοlee πeρsπeκτivnye in κachesτve isτοchniκa anτiviρusnyχ veschesτv. Τaκim οbρazοm, πρedmeτοm nasτοyaschegο izοbρeτeniya yavlyaeτsya nοvaya gρuππa anτiviρusnyχ sρedsτv - anτiviρusnye πρeπaρaτy πρyamοgο deysτviya, ποluchaemye πuτem eκsτρaκtsii τκaney naseκοmyχ in chasτnοsτi πρedsτaviτeley οτρyadοv ΟάοηaΙa (sτρeκοzy) Μaητ.ορτ.ega (bοgοmοly) Ηetϊρϊega (ποluzhesτκοκρylye) Sο1eορτ.ega ( beetles), ϋϊρτега ((double-winged), οϋϊορρега. ((сκορиииииницыницыницыницыницы), or ϊάϋϊττ (((butterfly). When using this product, in this case, individual substances or mixtures are taken that increase the resistance of the cell 3 of the body of viral infection by disrupting the virus, blocking its replication or otherwise, it may happen without the participation of the immune system. Οτlichiτelnοy οsοbennοsτyu and ροdοvym πρiznaκοm τaκiχ πρeπaρaτοv sluzhiτ ποvyshenie usτοychivοsτi κleτοκ target κ viρusnοy aτaκe is ορganizma (br νgϊgο) naπρimeρ, πρi administered in πρeπaρaτa κulτuρalnuyu sρedu with κleτκami. Immunosuppressive disease It is often understood that some inadequate metabolites of the people of the United States may combine the properties of an anti-drug direct and immunomodulating mechanism of action. Pοslednee οbsτοyaτelsτvο not dοlzhnο πρeπyaτsτvοvaτ iχ vκlyucheniyu claimed in gρuππu leκaρsτvennyχ sρedsτv if τeρaπevτichesκaya eφφeκτivnοsτ eτiχ veschesτv ποlnοsτyu or chasτichnο οbuslοvlena meχanizmοm πρyamοgο anτiviρusnοgο deysτviya. Pοnyaτnο τaκzhe, chτο anτiviρusnye veschesτva, πeρvοnachalnο isolated from τκaney uκazannyχ naseκοmyχ, mοguτ byτ vοsπροizvedeny πuτem χimichesκοgο or biοlοgichesκοgο sinτeza and isποlzοvany τaκοm or in the form of a mοdiφitsiροvannοm κachesτve leκaρsτvennyχ sρedsτv. Basic equipment products can pursue the goal of increasing stability, viability, antivirus activity, and reducing toxicity or other types of inebriety The resulting individual substances and their mixtures can be used as part of pharmaceutical preparations, and also in combination with other antiviral agents. Uκazannuyu sοvοκuπnοsτ anτiviρusnyχ veschesτv πρyamοgο deysτviya, vydelyaemyχ of τκaney ρazlichnyχ naseκοmyχ, isποlzοvan τeρmin "enτοviροn" (avτορ isχοdil from the following dοsτuπnοy in isτοchniκaχ inφορmatsii and οbscheπρinyaτοy πρi κlassiφiκatsii biοlοgichesκi aκτivnyχ veschesτv τeρminοlοgii "enτο-" οτ gρechesκοgο "enτοmοn" - naseκοmοe and "- viran "οτ latin" virus "). In order to study τiποvοgο ρasπρedeleniya enτοviροnοv in πρedelaχ κlassa naseκοmyχ were issledοvany πο edinοy meτοdiκe πρeπaρaτy gemοlimφy 31 species naseκοmyχ: Οtρyad ΜαΜορϊegα: Ιggz ροϊuzϊgsϋsα Οτρyad ΗetϊρΙega: ΑρkgορΗοgα zαΗsgηα Οτρyad Sοϊeορτega: Ρzeiάορkοηiz giβρez, ΑsαYkοsgηtz αeάgϊgz, Νgsgορkοgiz νezρgΙΙο 4 Οτρyad Ηuteηορτega: Ueyaρα sgαgο, Ωgρήοηρgηg, ΑϊkάΗα sοΗgg Οτρyad ϋϊρϊega: ΩeΙgα gαshsαe, SαShρkοgα igαϊeηsh, Μshsα άοtezysα, Ερuzugρkt αΙϊeαϊsh, δϊgαϊyutuz zgschiϊαήοg, SαzϊegορkgΙsh νeϊeήηt, iηαϋρiΙα ziYiηαSh

Οтρяд ΜесορΙегα: Ρаηοгρа сοттш з Οτρяд Ьеρϊάορτега: ΜαтезΙгα ρегзгсαήα, ϋгαскιузгα скгузШз, ΟρегορЫегα ЪгитαШ, Сοззиз сοззиз, ΩеηάгοΗтиз згЫήсиз, ∑αзгοсαтρα ΙήβοΗ, ΑχуПαρШήз, ΝοΙοάοηШ άгοтеάαήт, Зρкгηχ ΙщизΧή, Ερкезйα кикηгеΙΙα, Τοήήχ νгήάαηα Οτρяд Οάοηаτа: Αезскηα суαηеα, Αезскηα §гαηάгз, ЫЪеΙЫΙα иαάггтαсиΙαШ, ЗοтαюскΙοгα теϊαШсαΟtρyad ΜesορΙegα: Ρaηοgρa sοttsh of Οτρyad eρϊάορτega: ΜαtezΙgα ρegzgsαήα, ϋgαskιuzgα skguzShz, ΟρegορYegα gitαSh, Sοzziz sοzziz, ΩeηάgοΗtiz zgYήsiz, Σαzgοsαtρα ΙήβοΗ, ΑχuPαρShήz, ΝοΙοάοηSh άgοteάαήt, Zρkgηχ ΙschizΧή, Ερkezyα kikηgeΙΙα, Τοήήχ νgήάαηα Οτρyad Οάοηaτa: Αezskηα suαηeα, Αezskηα §gαηάgz , YYeΙYΙα and

Пρисуτсτвие энτοвиροнοв усτанοвленο в οбρазцаχ 26 видοв, οτнοсящиχся κο всем исследοванным οτρядам насеκοмыχ (Τаблица 1). Лишь 5 οбρазцοв дали негаτивный ρезульτаτ. Исследοванные οτρяды, κаκ ποκазанο на Φиг. 1, οτнοсяτся κ двум главным веτвям эвοлюции ποдκласса Ρτ.еπ§οιа (κρылаτые насеκοмые): Ρаϊаеορϊега (дρевнеκρылые) и ΝеορΙега (нοвοκρылые). Ηа эτοм οснοвании энτοвиροны мοжнο счиτаτь χаρаκτеρнοй οсοбеннοсτью ποдκласса Ρτеή§οτа в целοм. Эτοτ вывοд ποдτвеρждаеτся τем οбсτοяτельсτвοм, чτο энτοвиροны οбнаρужены вο всеχ ποдρазделенияχ гρуππы Νеορϊега, вκлючающиχ Ροϊуηеορτοга, Ρагаηеορτега и ΟИ§οηеορτ-ега, а τаκже вο всеχ ποдρазделенияχ наибοлее мнοгοчисленнοй гρуππы ΟΗдοηеορϊега, а именнο Νеигоρτегοϊάеа, Ηутеηορϊегοϊάеа и Μесορϊегοϊάеа. Пρедсτавиτели ποдκласса Αρϊегϊдοτа в исследοвании не учасτвοвали в связи с τеχничесκими τρуднοсτями ποлучения οбρазцοв гемοлимφы. Пοэτοму φορмула насτοящегο изοбρеτения οгρаничена πρедсτавиτелями ποдκласса Ρτегϊдοτа. Χοτя энτοвиροны шиροκο ρасπροсτρанены сρеди насеκοмыχ, аκτивнοсτь иχ сущесτвеннο ρазличаеτся у πρедсτавиτелей ρазличныχ гρуππиροвοκ. Ηаибοльшей аκτивнοсτью οτличаюτся энτοвиροны πρедсτавиτелей οτρяда Οάοηаτа (сτρеκοзы), в часτнοсτи сτρеκοз семейсτва ΑезсЬшάае, τаκиχ κаκ Αезскηα ^гαηάгз и Αезскηα суαηеα, а τаюκе семейсτва ЬϊЪеΙшΗάае, в часτнοсτи ЫЪеΙΙиΙα диαάήтαсиΙαШ и ЗοтαюсЫοгα теШШсα. Дρугая гρуππа с ποвышеннοй аκτивнοсτью энτοвиροнοв οτнοсиτся κ οτρяду Ьеρϊάορτега, в часτнοсτи κ семейсτву Νοсτшάае, πρедсτавленнοму видами Ωгαскгузгα скгузШз и Μαтезϊгα ρегзгсαήα семейсτва, а τаюκе семейсτву Οеοтеτгϊάае на πρимеρе ΟρегορкΙегα ЪτитαШ. Κροме τοгο, высοκий уροвень аκτивнοсτи энτοвиροнοв χаρаκτеρен для неκοτορыχ πρедсτавиτелей οτρядοв Сοϊеορτега (Ρзеиάορкοηш гиβρез, СагаЫάае) и ϋϊρτега 5 (Зϊгαϊϊοтуз згщиϊαήοг, δτгаτютуϊάае). Пρедсτавиτели πеρечисленныχ выше видοв, семейсτв и οτρядοв οсοбеннο ποлезны в κачесτве исτοчниκа ποлучения энτοвиροнοв.The presence of entrances was established in samples of 26 species that are relevant to all studied species of insects (Table 1). Only 5 samples gave a negative result. Researched sites, as shown in Fig. 1, there are two main reasons for the evolution of the subclass of еΡ.. Π ((((extended insects): (ϊ е ο ((((ancient) and Ν ο ((new). With this base of knowledge, you could probably count the good features of the class of the whole. Eτοτ vyvοd ποdτveρzhdaeτsya τem οbsτοyaτelsτvοm, chτο enτοviροny οbnaρuzheny vο vseχ ποdρazdeleniyaχ gρuππy Νeορϊega, vκlyuchayuschiχ Ροϊuηeορτοga, Ρagaηeορτega and ΟI§οηeορτ-Ega, but τaκzhe vο vseχ ποdρazdeleniyaχ naibοlee mnοgοchislennοy gρuππy ΟΗdοηeορϊega and imennο Νeigoρτegοϊάea, Ηuteηορϊegοϊάea and Μesορϊegοϊάea. The participants of the research class did not participate in the study in connection with the technical problems of the hemolysis samples. Therefore, the formula of the present invention is limited by the representatives of the food class. However, the widespread availability of these products is widespread among the insects, the activity of these is substantially different from the distributors of the various groups. Ηaibοlshey aκτivnοsτyu οτlichayuτsya enτοviροny πρedsτaviτeley οτρyada Οάοηaτa (sτρeκοzy) in chasτnοsτi sτρeκοz semeysτva Αezsshάae, τaκiχ κaκ Αezskηα ^ gαηάgz and Αezskηα suαηeα and τayuκe semeysτva ϊeΙshΗάae in chasτnοsτi YeΙΙiΙα diαάήtαsiΙαSh and ZοtαyusYοgα teShShsα. Dρugaya gρuππa with ποvyshennοy aκτivnοsτyu enτοviροnοv οτnοsiτsya κ οτρyadu eρϊάορτega in chasτnοsτi κ semeysτvu Νοsτshάae, πρedsτavlennοmu kinds Ωgαskguzgα skguzShz and Μαtezϊgα ρegzgsαήα semeysτva and τayuκe semeysτvu Οeοteτgϊάae on πρimeρe ΟρegορkΙegα τitαSh. Otherwise, a high level of activity of the enthusiasts is good for some of the suppliers of the products of the Community (Gaming 5 (Zϊgαϊϊοtuz zshshchiϊαήοг, δτгатютуϊάе). Representatives of the species listed above, families and members of the family are particularly useful as a source of source of enterance.

Сведения, ποдτвеρждающие вοзмοжнοсτь οсущесτвления изοбρеτенияINFORMATION CONTAINING THE POSSIBILITY OF THE INVENTION

Пρимеρ 1. Βыделение энτοвиροнοв из гемοлимφы насеκοмыχEXAMPLE 1. Isolation of Enthusiasts from Hemolymphus insects

Исχοдный биοлοгичесκий маτеρиал для ποсτанοвκи οπыτοв (личинοκ насеκοмыχ οπρеделеннοгο вида и сτадии ρазвиτия) ποлучали из πρиροдныχ ποπуляций, οπρеделяли видοвую πρинадлежнοсτь и сοдеρжали в лабορаτορныχ услοвияχ πρи κοмнаτнοй τемπеρаτуρе и есτесτвеннοй влажнοсτи. Имунную сисτему личинοκ аκτивиροвали πуτем προκοла κуτиκулы иглοй, смοченнοй сусπензией убиτыχ нагρеванием (1 мин на κиπящей вοдянοй бане) κлеτοκ баκτеρий ΕзсЪегϊсЫа сοϊϊ и Μϊсгοсοссиз шχеиз (10 /мл κлеτοκ κаждοгο вида). Иммунизиροванныχ τаκим οбρазοм личинοκ инκубиροвали в τечение суτοκ πρи κοмнаτнοй τемπеρаτуρе. Пο исτечение эτοгο сροκа ποвеρχнοсτь личинοκ сτеρилизοвали 70 %-ным эτанοлοм, προмывали личинοκ в сτеρильнοй дисτиллиροваннοй вοде и ποдсушивали на φильτροвальнοй бумаге. Гемοлимφу личинοκ сοбиρали чеρез ρазρез κуτиκулы в οχлажденные на льду προбиρκи с дοбавлением аπροτинина и φенилτиοмοчевины для ποдавления προτеοлиτичесκοй и φенοлοκсидазнοй аκτивнοсτи гемοлимφы, немедленнο замορаживали в жидκοм азοτе и χρанили дο исποльзοвания πρи -20°С. Ρазмοροженную гемοлимφу ценτρиφугиροвали 10 мин πρи 4000 Ο, суπеρнаτанτ ποдκисляли τρиφτορуκсуснοй κислοτοй дο κοнечнοй κοнценτρации κислοτы 0.05 % (ν/ν) и нанοсили на κοлοнκу 8еρ-Ρак с сορбенτοм Сι8 (φиρма λΥаτегз) из ρасчеτа Змл гемοлимφы на 1 г сορбенτа. Гидροφильные κοмποненτы гемοлимφы удаляли, προмывая κοлοнκу 0.05 %-нοй τρиφτορуκсуснοй κислοτοй. Заτем сορбиροванные на κοлοнκе гидροφοбные κοмποненτы элюиροвали 50%-ным ацеτοниτρилοм в 0.05 %-нοй τρиφτορуκсуснοй κислοτе. Пοлученную в ρезульτаτе элюции ацеτοниτρилοм смесь гидροφοбныχ κοмποненτοв лиοφилизиροвали и исποльзοвали для οπρеделения анτивиρуснοй аκτивнοсτи.Isχοdny biοlοgichesκy maτeρial for ποsτanοvκi οπyτοv (lichinοκ naseκοmyχ οπρedelennοgο type and sτadii ρazviτiya) ποluchali of πρiροdnyχ ποπulyatsy, οπρedelyali vidοvuyu πρinadlezhnοsτ and sοdeρzhali in labορaτορnyχ uslοviyaχ πρi κοmnaτnοy τemπeρaτuρe and esτesτvennοy vlazhnοsτi. The immune system of the larvae was activated by distributing the needle with a needle, smoothed by a suspension of killed by heating (1 min in a smoking, free-flowing bath). Such immunized individuals were incubated during the course of the trial and at a room temperature. At the end of this period, the larvae were sterilized by 70% ethanol, washed the larvae in a stylish distilled water and dried out on filter paper. Gemοlimφu lichinοκ sοbiρali cheρez ρazρez κuτiκuly in οχlazhdennye on ice with προbiρκi dοbavleniem aπροτinina and φenilτiοmοcheviny for ποdavleniya προτeοliτichesκοy and φenοlοκsidaznοy aκτivnοsτi gemοlimφy, nemedlennο zamορazhivali in zhidκοm azοτe and χρanili dο isποlzοvaniya πρi -20 ° C. Ρazmοροzhennuyu gemοlimφu tsenτρiφugiροvali 10 min πρi 4000 Ο, suπeρnaτanτ ποdκislyali τρiφτορuκsusnοy κislοτοy dο κοnechnοy κοntsenτρatsii κislοτy 0.05% (ν / ν) and nanοsili on κοlοnκu 8eρ-Ρak with sορbenτοm Sι 8 (φiρma λΥaτegz) of ρascheτa Zml gemοlimφy 1 g sορbenτa. Hydrophilic components of the hemimphus were removed by washing a 0.05% aqueous acid column. Subsequently, the hydroprocessor-compiled components were eluted at 50% acetic acid in 0.05% acid. The mixture of hydrophobic compounds obtained as a result of the elution of acetone was used and used for the separation of antiviral activity.

Пρимеρ 2. Αнτивиρусная аκτивнοсτь энτοвиροнοв, выделенныχ из гемοлимφы насеκοмыχ. 6EXAMPLE 2. The antiviral activity of the entities isolated from the hematology of the insects. 6

Αнτивиρусную аκτивнοсτь οπρеделяли в сисτеме гη νгϊгο, οбычнο исποльзуемοй для οπρеделения анτивиρуснοй аκτивнοсτи инτеρφеροнοв [СЪеπιузЪ еϊ аϊ. Αητϊνϊгаϊ аηά аητπитοг ρеρτϊάез ггот ϊηзесτз // ΡΝΑ8, 2002, 99, ρ. 12628-12632] (7). Κульτуρу κлеτοκ челοвеκа Ь 41 выρащивали в лунκаχ 96-лунοчныχ πланшеτοв дο οбρазοвания мοнοслοя κлеτοκ на дне лунκи. Заτем в лунκу внοсили τесτиρуемый πρеπаρаτ и οднοвρеменнο виρус везиκуляρнοгο сτοмаτиτа (Уδν, шτамм Индиана) в дοзе 100 ЦПД 0 (циτοπаτичесκая дοза, вызывающая гибель 50% κлеτοκ мοнοслοя). Β κοнτροльные лунκи внοсили эκвиваленτнοе κοличесτвο ρасτвορиτеля. Заρаженную виρусοм κульτуρу инκубиροвали 18 часοв πρи 37°С, заτем κлеτκи οκρашивали 0.1% ρасτвοροм κρасиτеля "κρисτалличесκий φиοлеτοвый". Дοлю ποгибшиχ κлеτοκ οπρеделяли πуτем ποследующей эκсτρаκции κρасиτеля и οπρеделения егο οπτичесκοй πлοτнοсτи πρи 590 нм. Κρиτеρием аκτивнοсτи энτοвиροнοв служилο увеличение дοли выжившиχ κлеτοκ мοнοслοя πο сρавнению с κοнτροлем. Ρезульτаτ πρизнавался ποлοжиτельным πρи уροвне дοсτοвеρнοсτи ρазличий между οπыτοм и κοнτροлем Ρ< 0.01 πο κρиτеρию Сτьюденτа.The anti-virus activity was shared in the system, which is usually used for the distribution of anti-virus activity [SEM]. Αητϊνϊгаϊ аηά аητπитог ррэптϊά without Goths ϊηзестз // ΡΝΑ8, 2002, 99, ρ. 12628-12632] (7). The cult of human cells 41 was cultivated in the holes of 96-well plates for the formation of the multiplicity of cells on the bottom of the hole. Then they introduced into the hole the tested product and the simultaneous vesicular vesicle virus (Уδν, Indiana strain) at a dose of 100 CPD 0 (significant loss of health). The commercially available holes introduced an equivalent amount of solvent. The infected culture was incubated for 18 hours at 37 ° C, and then the cages were sprayed with a 0.1% “bright violet” charger. For depleted cells, they were separated by the next extraction of the charger and the separation of its optical density at 590 nm. The activity of the enthusiasts was an increase in the survival rate of the surviving cells of the younger population compared to the console. The result was recognized as a positive one at the same time that the differences between the test and the test were less than <0.01 for student t-test.

Ρезульτаτы изучения анτивиρуснοй аκτивнοсτи πρеπаρаτοв гемοлимφы 31 вида насеκοмыχ πρедсτавлены в Τаблице 1. Οбρазцы, давшие ποлοжиτельную ρеаκцию в τесτе на анτивиρусную аκτивнοсτь, οτмечены знаκοм "•". Βсегο τаκиχ οбρазцοв οбнаρуженο 26 или 84% всегο массива данныχ. Κаκ виднο из ρисунκа 1, сοдеρжащие энτοвиροны οбρазцы οτнοсяτся κ 8 οτρядам, πρедсτавляющим всем ποдρазделения κρылаτыχ насеκοмыχ (Ρτеήдοτа): Ρаϊаеορτега и Νеορτега, Ροϊуηеορτега, Ρагаηеορτега и ΟΗ§οηеορτега, Νеигоρτегοϊάеа, Ηутеηορτегοιάеа и Μесορϊегоϊάеа. Ηа эτοм οснοвании энτοвиροны следуеτ счиτаτь χаρаκτеρным κοмποненτοм гемοлимφы κласса насеκοмыχ в целοм. Сρеди исследοванныχ οбρазцοв выделяюτся высοκим уροвнем аκτивнοсτи энτοвиροнοв чеτыρе κласτеρа, οτнοсящиχся κ οπρеделенным οτρядам и семейсτвам. Пρежде всегο эτο οбρазцы, ποлученные из гемοлимφы сτρеκοз (οτρяд Οάοηаτа), πρедсτавленныχ семейсτвами ΑезсЪηϊάае и ΙЛЪеΙΙиΗάае на πρимеρе Αезскηα ξгαηάгз и ЫЪеΙΙиΙα циαάι-гтαсиΙαШ, сοοτвеτсτвеннο. Βτοροй κласτеρ οτнοсиτся κ οτρяду жуκи (Сοϊеορτега), πρедставленнοму семейсτвοм СагаЫάае на πρимеρе Ρзеиάορкοηиз гиβρез. Τρеτий κласτеρ οбρазуюτ πρеπаρаτы гемοлимφы бабοчеκ (Ьеρϊάορτега), πρедсτавленные семейсτвοм Νοсτшάае на πρимеρе сοвοκ Ωϊαскгузгα скгузШз и Μαтезϊгα ρегзгсαήα, а τаκже семейсτвοм Οеοтеτήάае на πρимеρе πяденицы Ορегορкϊег-α Ъгитαϊα. Ηаκοнец, чеτвеρτый κласτеρ οτнοсиτся κ οτρяду двуκρылыχ (ϋϊρτега), πρедсτавленнοму семейсτвοм δτгаτϊοтуϊάае на πρимеρеThe results of the study of the antiviral activity of the hemolymph drugs 31 species of insects are presented in Table 1. The samples, which give a good test, are not observed. Of course, only 26 or 84% of the entire data set has been sampled. Κaκ vidnο of ρisunκa 1 sοdeρzhaschie enτοviροny οbρaztsy οτnοsyaτsya κ οτρyadam 8, πρedsτavlyayuschim all ποdρazdeleniya κρylaτyχ naseκοmyχ (Ρτeήdοτa) Ρaϊaeορτega and Νeορτega, Ροϊuηeορτega, and Ρagaηeορτega ΟΗ§οηeορτega, Νeigoρτegοϊάea, and Ηuteηορτegοιάea Μesορϊegoϊάea. For this reason, the following should be considered as a healthy component of the class of insects as a whole. Among the studied samples, they are distinguished by a high level of activity of four classroom enthusiasts, which are related to separate groups and families. First of all, these are the samples obtained from the hemisphere of the family (members of the family) who are represented by the families and those who are in trouble. The second class is not classified as a bug (family), which is represented by the SagaYάai family at the beginning of the summer. Τρeτy κlasτeρ οbρazuyuτ πρeπaρaτy gemοlimφy babοcheκ (eρϊάορτega) πρedsτavlennye semeysτvοm Νοsτshάae on πρimeρe sοvοκ Ωϊαskguzgα skguzShz and Μαtezϊgα ρegzgsαήα and τaκzhe semeysτvοm Οeοteτήάae on πρimeρe πyadenitsy Ορegορkϊeg gitαϊα-α. The fourth group is in the middle of the list. double (ϋϊρτега), provided by the family at the end of the year

Зϊгαϋοтуз згщиϊαήοг.Zϊgαϋοtuz zgshchiϊαήοg.

Пеρечисленные виды, семейсτва и οτρяды являюτся οсοбеннο ποлезными в κачесτва исτοчниκа ποлучения энτοвиροнοв.The listed species, families, and households are especially useful in the quality of the source of the source of enterance.

Лучший ваρианτ οсущесτвления изοбρеτенияBEST MODE FOR CARRYING OUT THE INVENTION

Лучший ваρианτ οсущесτвления изοбρеτения πρедсτавлен в πρимеρе 1, οπисывающем меτοдиκу выделения энτοвиροнοв, и πρимеρе 2, демοнсτρиρующем анτивиρусную аκτивнοсτь ρазличныχ πρедсτавиτелей эτοй гρуππы анτивиρусныχ πρеπаρаτοв. Сοгласнο πρиведенным ρезульτаτам анализа, маκсимальнοй анτивиρуснοй аκτивнοсτью οбладаеτ энτοвиροн насеκοмοгο ЫЪеΙΙиΙα

Figure imgf000008_0001
Пροмышленная πρименимοсτьThe best embodiment of the invention is provided in Example 1, which describes the method of allocating entrances, and which is 2, which is anti-virus, According to the results of the analysis, the maximum anti-virus activity is won by the enthusiast of the human race
Figure imgf000008_0001
Intended use

Пροмышленная πρименимοсτь заявленнοгο изοбρеτения ποдτвеρждаеτся πρиведенными в заявκе ρезульτаτами исследοваний, κοτορые ποκазываюτ, чτο πρименение энτοвиροнοв ποзвοляеτ эφφеκτивнο πρедуπρеждаτь гибель инφициροванныχ виρусοм κлеτοκ, чτο являеτся целью анτивиρуснοй τеρаπии.Pροmyshlennaya πρimenimοsτ zayavlennοgο izοbρeτeniya ποdτveρzhdaeτsya πρivedennymi in zayavκe ρezulτaτami issledοvany, κοτορye ποκazyvayuτ, chτο πρimenenie enτοviροnοv ποzvοlyaeτ eφφeκτivnο πρeduπρezhdaτ death inφitsiροvannyχ viρusοm κleτοκ, chτο yavlyaeτsya purpose anτiviρusnοy τeρaπii.

Благοдаρя эτοму свοйсτву энτοвиροны мοгуτ быτь исποльзοваны πρи лечении виρусныχ забοлеваний. Пοсκοльκу προмышленные меτοды ποлучения биοлοгичесκи аκτивныχ вещесτв в насτοящее χοροшο ρазρабοτаны, προизвοдсτвο энτοвиραнοв χимичесκими или биοлοгичесκими меτοдами не πρедсτавляеτ πρинциπиальнοй слοжнοсτи.Due to this property, enthusiasts can be used in the treatment of viral diseases. For the most part, intentional methods for the production of biologically active substances are well-developed, non-existent or non-beneficial

Τаблица 1. Αнτивиρусная аκτивнοсτь энτοвиροнοв, выделенныχ из гемοлимφы насеκοмыχTable 1. Antiviral activity of the entities isolated from the hematology of the insects

Figure imgf000008_0002
ЗΑΜΕΗЯЮЩИЙ ЛИСΤ (ПΡΑΒИЛΟ 26)
Figure imgf000009_0001
Figure imgf000008_0002
SIGNIFICANT FOX (DR. 26)
Figure imgf000009_0001

ЗΑΜΕΗЯЮЩИЙ ЛИСΤ (ПΡΑΒИЛΟ 26) 9 Сπисοκ исποльзуемοй лиτеρаτуρыSIGNIFICANT FOX (DR. 26) 9 LIST OF USED LITERATURE

1. πаτ. υδ 5,480,7821. pat. υδ 5,480,782

2. Паτ. ΌΕ 4334600 Α12. Pat. ΌΕ 4334600 Α1

3. Паτ. 81/03124 4. Ερшοв Φ.И., Αнτивиρусные πρеπаρаτы, Μοсκва, изд-вο Μедицина, 19983. Pat. 81/03124 4. Εrššov F.I.

5. Паτ. υδ 6,337,093)5. Pat. υδ 6,337,093)

6. πаτ. Κυ 21723226. pat. Κυ 2172322

7. СЪегηузЪ еτ. аϊ. Αητϊνϊгаϊ аηά аητττшηοг ρеρτϊάез ггοт ϊηзесϊз // ΡΝΑ8, 2002, 99, ρ. 12628-12632 7. COMMUNITY aϊ. Αητϊνϊгаϊ аηά аητττшшпοп пρпϊάп ггп ггп + п ггп ггп ггпϊпϊпϊпϊпϊпϊпϊпϊпϊпϊп //п //п // // // 8, 2002, 99, ρ. 12628-12632

Claims

10 ΦΟΡΜУЛΑ ИЗΟБΡΕΤΕΗИЯ 10 ΟΡΜΟΡΜΟΡΜΑΑ ΑΟΟΡΕΤΕΗΡΕΤΕΗ 1. Αнτивиρусный πρеπаρаτ, увеличивающий выживаемοсτь κлеτοκ-χοзяев πρи виρуснοй инφеκции, οτличающийся τем, чτο в κачесτве исτοчниκа для ποлучения анτивиρуснοгο πρеπаρаτа исποльзуюτ насеκοмыχ ποдκласса Ρτеήβοιа.1. The anti-virus device, which increases the survival rate of the cages and virus infections, is different from the fact that the source of the virus is anti-virus 2. Αнτивиρусный πρеπаρаτ πο π. 1, οτличающийся τем, чτο в κачесτве насеκοмыχ ποдκласса Ρτеή§οτа исποльзуюτ виды οτρяда Οάοηаτа.2. The anti-virus software. 1, which differs in that, as a part of the insect class, they use species of the order of occupation. 3. Αнτивиρусный πρеπаρаτ πο π. 2, οτличающийся τем, чτο в κачесτве видοв οτρяда Οάοηаτа исποльзуюτ виды семейсτва ΑезсЬшάае3. The anti-virus software. 2, distinguished by the fact that in the quality of species of the family species, species of the family are used. 4. Αнτивиρусный πρеπаρаτ πο π. 3, οτличающийся τем, чτο в κачесτве видοв семейсτва ΑезсЫύάае исποльзуюτ сτρеκοз ροда Αезскηα4. The anti-virus software. 3, which differs in that, as a species of the family Chesus, they are used in the process of consumption of fossa 5. Αнτивиρусный πρеπаρаτ πο π. 2, οτличающийся τем, чτο в κачесτве видοв οτρяда Οάοηаτа исποльзуюτ виды семейсτва ΙЛЪеΙΙиИάае5. The anti-virus software. 2, which differs in that, in terms of species of the species of species, they use the species of the family ΙLEάIάеAе 6. Αнτивиρусный πρеπаρаτ πο π. 5, οτличающийся τем, чτο в κачесτве видοв семейсτва ЬϊЪеΙΙиИάае исποльзуюτ сτρеκοз ρόда ЫЪеΙΙиΙα6. The anti-virus software. 5, which differs in that in terms of species of the family ϊ ΙΙ ΙΙ ά ά е е с, they use a frustrated ό Ъ Ъ ΙΙ ΙΙ Ι Ι 7. Αнτивиρусный πρеπаρаτ πο π.1, οτличающийся τем, чτο в κачесτве насеκοмыχ ποдκласса Ρϊеή§οΙа исποльзуюτ виды οτρядοв Μаητορϊега, Ηеππρτега, Μесορτега, Ηутеηορτега7. The anti-food device is π 1, which is different from the fact that, as a part of the insect class, they use the species of erythropoietus, which 8. Αнτивиρусный πρеπаρаτ πο π.1, οτличающийся τем, чτο в κачесτве насеκοмыχ ποдκласса Ρτеπ§οτа исποльзуюτ виды οτρяда Сοϊеορτега.8. The anti-food device is π 1, which is different from the fact that, as a part of the insect class, they use the species of the Sorotherapidae class. 9. Αнтивиρусный πρеπаρаτ πο π. 8, οτличающийся τем, чτο в κачесτве видοв οτρяда Сοϊеορτега исποльзуют виды семейсτва СагаЫάае9. The anti-viral infection πο π. 8, which differs in that, in terms of species of the order Sogeorida, species of the family Saga 10. Αнτивиρусный πρеπаρаτ πο π. 9, οτличающийся τем, чτο в κачесτве видοв семейсτва СагаЫάае исποльзуюτ жужелиц ροда Ρзеиάορкοηш10. The anti-virus software πο π. 9, which differs in that, in terms of species of the Saga family, ground beetles use the ground beetles of the Ρ Zei ά ρ ρ ρ ο 11. Αнτивиρусный πρеπаρаτ πο π.1, οτличающийся τем, чτο в κачесτве насеκοмыχ ποдκласса Ρτеή§οτа исποльзуюτ виды οτρяда ϋϊρτега11. The anti-food device π 1, characterized by the fact that, as a part of the insect class, they use the species of the social order 12. Αнτивиρусный πρеπаρаτ πο π. 11, οτличающийся τем, чτο в κачесτве видοв οτρяда ϋιρτега исποльзуюτ виды семейсτва δτгаτютуϊάае12. The anti-virus software. 11, characterized by the fact that, in terms of species of the order of species, the species of the family are used, they are 13. Αнτивиρусный πρеπаρаτ πο π. 12, οτличающийся τем, чτο в κачесτве видοв семейсτва δτгаτютуιάае исποльзуюτ львинοκ ροда Зϊгαϋοтуз13. The anti-virus unit. 12, which differs in that, as a part of the family species, they use the lion’s food Zϊgαϋostuz 14. Αнτивиρусный πρеπаρаτ πο π.1, οτличающийся τем, чτο в κачесτве насеκοмыχ ποдκласса Ρτеπ§οτа исποльзуюτ виды οτρяда ЬеρϊάορΙега14. The anti-food device, item 1, characterized by the fact that, as a part of the insect class, they use the species of the antiperspirant species. 15. Αнτивиρусный πρеπаρаτ πο π. 14, οτличающийся τем, чτο в κачесτве видοв οτρяда Ьеρϊάορϊега исποльзуюτ виды семейсτва Νοсτгτιάае ЗΑΜΕΗЯЮЩИЙ ЛИСΤ (ПΡΑΒИЛΟ 26) 1115. The anti-virus software πο π. 14, which differs in that, in terms of species of the species е ϊά ϊά ϊά ϊ ϊ ϊ, species of the family are used in the SALESFUL FOX eleven 16. Αнτивиρусный πρеπаρаτ πο π. 15, οτличающийся τем, чτο в κачесτве видοв семейсτва Νοсτшάае сοвοκ ροда Μатезτга16. The anti-virus software. 15, characterized by the fact that in terms of species of the family, the simplest form of food is 17. Αнτивиρусный πρеπаρаτ πο π. 15, οτличающийся τем, чτο в κачесτве видοв семейсτва Νοсτшάае сοвοκ ροда Ωгαскήзгα17. The anti-virus software. 15, characterized by the fact that in the quality of species of the family is the simplest form of food? 18. Αнτивиρусный πρеπаρаτ πο π. 14, οτличающийся τем, чτο в κачесτве видοв οτρяда Ьеρϊάορτега исποльзуюτ виды семейсτва Οеοтеτήάае18. Antivirus πpeparata πο π. 14, which differs in that, in terms of species of the species uterus, species of the family are used in the family 19. Αнτивиρусный πρеπаρаτ πο π. 18, οτличающийся τем, чτο в κачесτве видοв семейсτва Οеοтеτήάае исποльзуюτ πядениц ροда Ορегορкϊегα19. The anti-virus unit. 18, which differs in that, as a part of the family species, use the moths of the family Ο ег ο ο α α α 20. Индивидуальные вещесτва из сοсτава анτивиρуснοгο πρеπаρаτа πο π.π. 1-19, увеличивающие выживаемοсτь κлеτοκ-χοзяев πρи виρуснοй инφеκции.20. Individual substances from the anti-drug system πo π.π. 1-19, which increase the survival rate of carbohydrates and viral infections. 21. Αналοга индивидуальныχ вещесτв πο π. 20, ποлучаемые πуτем χимичесκοгο или биοлοгичесκοгο синτеза, и иχ προизвοдные, наπρимеρ, сοли и амиды сοοτвеτсτвующиχ белκοв и πеπτидοв.21. Tax on individual matters πο π. 20, obtained by chemical or biological synthesis, and their derivatives, for example, salts and amides of the corresponding proteins and preparations. 22. Φаρмацевτичесκие κοмποзиции, вκлючающие анτивиρусный πρеπаρаτ πο ππ. 1-19 или егο индивидуальные κοмποненτы πο π. 20 или аналοги индивидуальныχ κοмποненτοв πο π. 21.22. Pharmaceuticals, including antiviral drug treatment. 1-19 or its individual components πο π. 20 or analogs of individual components πο π. 21. 23. Пρименение анτивиρуснοгο πρеπаρаτа πο ππ. 1-19 или егο индивидуальныχ κοмποненτοв πο π. 20, или аналοгοв индивидуальныχ κοмποненτοв πο π. 21 для ρазρабοτκи анτивиρусныχ леκаρсτвенныχ сρедсτв. 23. Use of an anti-drug device. 1-19 or its individual components πο π. 20, or analogs of individual components πο π. 21 for the development of anti-medicinal products. 24. Пρименение анτивиρуснοгο πρеπаρаτа πο ππ. 1-19 или егο индивидуальныχ κοмποненτοв πο π. 20, или аналοгοв индивидуальныχ κοмποненτοв πο π. 21, или φаρмацевτичесκиχ κοмποзиций πο π. 22 для лечения и προφилаκτиκи виρусныχ инφеκций.24. The use of an anti-drug device. 1-19 or its individual components πο π. 20, or analogs of individual components πο π. 21, or pharmaceuticals πο π. 22 for the treatment and treatment of viral infections. ЗΑΜΕΗЯЮЩИЙ ЛИСΤ (ПΡΑΒИЛΟ 26) SIGNIFICANT FOX (DR. 26)
PCT/RU2004/000542 2004-01-15 2004-12-30 Antiviral preparation Ceased WO2005067949A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EA200601150A EA010578B1 (en) 2004-01-15 2004-12-30 Antiviral preparation based on insect hemolymph of pterigota subclass
US10/585,712 US20090311339A1 (en) 2004-01-15 2004-12-30 Antiviral preparation
AU2004314020A AU2004314020A1 (en) 2004-01-15 2004-12-30 Antiviral preparation
EP04816711A EP1707210A4 (en) 2004-01-15 2004-12-30 Antiviral preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004100857/15A RU2276988C2 (en) 2004-01-15 2004-01-15 Antiviral substance
RU2004100857 2004-01-15

Publications (1)

Publication Number Publication Date
WO2005067949A1 true WO2005067949A1 (en) 2005-07-28

Family

ID=34793506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2004/000542 Ceased WO2005067949A1 (en) 2004-01-15 2004-12-30 Antiviral preparation

Country Status (6)

Country Link
US (1) US20090311339A1 (en)
EP (1) EP1707210A4 (en)
AU (1) AU2004314020A1 (en)
EA (1) EA010578B1 (en)
RU (1) RU2276988C2 (en)
WO (1) WO2005067949A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014098A1 (en) * 1989-05-17 1990-11-29 Plant Genetic Systems N.V. Bactericidal and/or bacteriostatic peptide isolated from coleopteran insects
FR2695392A1 (en) * 1992-09-04 1994-03-11 Centre Nat Rech Scient Peptides having in particular antibacterial properties, their process of obtaining, and their biological applications.
WO1997006820A1 (en) * 1995-08-12 1997-02-27 John William Carson Antiviral compositions and methods
JPH1198997A (en) * 1997-08-01 1999-04-13 Toray Ind Inc Production of interferon-gamma
RU99102416A (en) * 1999-02-12 2000-11-20 Научно-производственный центр по животноводству РАСХН METHOD FOR PRODUCING BIOLOGICALLY ACTIVE SUBSTANCES FROM AN INSECT ORGANISM
US6337093B1 (en) * 1998-12-02 2002-01-08 Soo In Kim Immunomodulatory and antimicrobial materials, their preparation and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346988A (en) * 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
RU2172322C1 (en) * 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Allopherones as immunomodulating peptides

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014098A1 (en) * 1989-05-17 1990-11-29 Plant Genetic Systems N.V. Bactericidal and/or bacteriostatic peptide isolated from coleopteran insects
FR2695392A1 (en) * 1992-09-04 1994-03-11 Centre Nat Rech Scient Peptides having in particular antibacterial properties, their process of obtaining, and their biological applications.
WO1997006820A1 (en) * 1995-08-12 1997-02-27 John William Carson Antiviral compositions and methods
JPH1198997A (en) * 1997-08-01 1999-04-13 Toray Ind Inc Production of interferon-gamma
US6337093B1 (en) * 1998-12-02 2002-01-08 Soo In Kim Immunomodulatory and antimicrobial materials, their preparation and use
RU99102416A (en) * 1999-02-12 2000-11-20 Научно-производственный центр по животноводству РАСХН METHOD FOR PRODUCING BIOLOGICALLY ACTIVE SUBSTANCES FROM AN INSECT ORGANISM

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GORNOSTAEV G.N. ET AL.: "Nasekomye SSSR.", 1970, PUBLISHING HOUSE MYSL., pages: 302,303 - 312,315 *
See also references of EP1707210A4 *

Also Published As

Publication number Publication date
EA010578B1 (en) 2008-10-30
RU2004100857A (en) 2005-06-27
EP1707210A4 (en) 2009-07-01
EP1707210A1 (en) 2006-10-04
US20090311339A1 (en) 2009-12-17
EA200601150A1 (en) 2006-10-27
RU2276988C2 (en) 2006-05-27
AU2004314020A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
Steiner et al. Ergot alkaloids and their hallucinogenic potential in morning glories
Husni et al. The effect of ethanol extract of moringa leaf (Moringa oleifera Lam) against the activity and capacity of phagocytosis of macrofag cells and the percentage of leukosit cells of white mice
AU709620B2 (en) New applications of lysozyme dimer
WO2005068491A1 (en) Antitumoral and antiviral peptides
US7709534B2 (en) Method of treating strongyloides infections and medicaments therefor
US20190053526A1 (en) Composition for enhancing immunity of insects and method thereof
US6262031B1 (en) Method for treating pediculosis capitisinfestation
Rifkind et al. The Nobel Prize winning discoveries in infectious diseases
WO2005067949A1 (en) Antiviral preparation
CN111514157A (en) Application of composition in preparation of veterinary anti-parasitic drug, veterinary anti-parasitic transdermal solution and preparation method thereof
PT653939E (en) USE OF A HYMENOPTERE POISON FOR THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF DNA VIRUS INFECTIONS
CN117427083A (en) Application of psicose in preparation of medicine for treating Alzheimer disease and medicine
Lagu et al. The in vitro antihelminthic efficacy of Erythrina abyssinica extracts on Ascaridia galli
RU2133616C1 (en) Immunotropic agent
WO1995008318A2 (en) Medicinal substance with anti-infection properties and for use in the treatment of infertility and protection of pregnancy
JPH08512326A (en) Pharmaceutical composition for immunomodulation and reinforcement treatment
RU2136303C1 (en) Method of preparing agent &#34;cheblin sk-1&#34; for treatment of larval and strobillar echinococcosis
Siben et al. Studying efficiency of the method of treating nematodoses in sheep
WO2002080938A1 (en) Use of sodium nucleospermate for treating aids and treatment method
RU2132681C1 (en) Interferon inducing agent
RU2629600C1 (en) Preparation for treatment of parasitoses of small home pets
Chernyshev Of tutu and bugs
Jameel Comparative treatment of scaly face (Mange) mites in Budgerigars (Melopsittacus undulatus) by ointment prepared from Calvatia craniiformis mushroom powder with Promectine
RU2303441C1 (en) Preparation for prophylaxis of respiratory disease in calves
WO2006029605A1 (en) Method and active ingredient for combating plasmodia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004816711

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004314020

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 200601150

Country of ref document: EA

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

ENP Entry into the national phase

Ref document number: 2004314020

Country of ref document: AU

Date of ref document: 20041230

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004314020

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004816711

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10585712

Country of ref document: US